Mink Therapeutics, INC. (INKT) — DEF 14A Filings
All DEF 14A filings from Mink Therapeutics, INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
MiNK Therapeutics Files 2025 Proxy Statement
— Apr 30, 2025 Risk: medium
MiNK Therapeutics, Inc. filed its definitive proxy statement on April 30, 2025, for the fiscal year ending December 31, 2024. The company, formerly known as Age -
MiNK Therapeutics Files Definitive Proxy Statement
— Dec 20, 2024 Risk: low
MiNK Therapeutics, Inc. filed its Definitive Proxy Statement (DEF 14A) on December 20, 2024, for its fiscal year ending December 31, 2025. The filing pertains t -
MiNK Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
MiNK Therapeutics, Inc. (INKT) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. MiNK Therapeutics will hold its 2024 Annual Meeting of Stockhol
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX